A detailed history of Utah Retirement Systems transactions in Moderna, Inc. stock. As of the latest transaction made, Utah Retirement Systems holds 53,282 shares of MRNA stock, worth $1.96 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
53,282
Previous 53,182 0.19%
Holding current value
$1.96 Million
Previous $6.32 Million 43.63%
% of portfolio
0.04%
Previous 0.08%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $6,364 - $12,514
100 Added 0.19%
53,282 $3.56 Million
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $445,324 - $733,084
-4,400 Reduced 7.64%
53,182 $6.32 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $20,853 - $31,329
300 Added 0.52%
57,582 $5.73 Million
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $38,564 - $50,644
-400 Reduced 0.69%
57,282 $5.92 Million
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $165,900 - $224,742
-1,400 Reduced 2.37%
57,682 $7.01 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $27,132 - $39,404
200 Added 0.34%
59,082 $9.07 Million
Q4 2022

Feb 15, 2023

SELL
$118.38 - $210.04 $201,246 - $357,068
-1,700 Reduced 2.81%
58,882 $10.6 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $82,649 - $135,926
-700 Reduced 1.14%
60,582 $7.16 Million
Q2 2022

Aug 16, 2022

BUY
$117.13 - $176.59 $105,417 - $158,931
900 Added 1.49%
61,282 $8.75 Million
Q1 2022

May 13, 2022

SELL
$126.46 - $235.05 $126,460 - $235,050
-1,000 Reduced 1.63%
60,382 $10.4 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $30,937 - $50,485
137 Added 0.22%
61,382 $15.6 Million
Q3 2021

Nov 16, 2021

SELL
$221.9 - $484.47 $722,284 - $1.58 Million
-3,255 Reduced 5.05%
61,245 $23.6 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $1.27 Million - $2.3 Million
9,800 Added 17.92%
64,500 $15.2 Million
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $272,950 - $464,950
-2,500 Reduced 4.37%
54,700 $7.16 Million
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $164,350 - $424,650
2,500 Added 4.57%
57,200 $5.98 Million
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $2.36 Million - $4.13 Million
43,500 Added 388.39%
54,700 $3.87 Million
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $53,406 - $144,000
1,800 Added 19.15%
11,200 $719,000
Q1 2020

May 15, 2020

BUY
$17.78 - $31.58 $167,132 - $296,852
9,400 New
9,400 $282,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Utah Retirement Systems Portfolio

Follow Utah Retirement Systems and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.